Figure 1 shows venture capital commitments — the amount of money that the industry has invested in startup companies measured in inflation-adjusted dollars — from 1980 to 2014. The dotted line in the figure is the five-year moving average.
Since the venture capital bubble burst in 2001, the trend in venture capital commitments has been largely downward, with a slight rise in the pre-financial crisis period. The most recent year data are available, 2014, shows an uptick, reversing the downward trend in the moving average.
The rash of headline-grabbing cyberattacks on major companies over the past few years has made one thing abundantly clear: it’s not enough to rely only on traditional security tools. To venture capitalists, that means there’s money to be made by betting on startups developing new ones.
Investing in startups is not an easy job. As an investor, you are not only betting on a specific startup and team, but often on a market that doesn’t yet exist. Even the best team in the world is doomed to fail if it bets on the wrong market. The opposite is not always true.
Magnum Capital Industrial Partners, la firma de capital riesgo liderada por Ángel Corcóstegui, empieza 2016 con ganas de seguir liquidando su cartera de cara a levantar con mejores rentabilidades su segundo fondo de 'private equity'. La entidad, después de haberse desprendido de Geriatros, Clínica Teknom e Iberwind, ha puesto a la venta Generis, la farmacéutica de origen portugués que compró hace seis años por unos 200 millones.
Invention and innovation drive the U.S. economy. What’s more, they have a powerful grip on the nation’s collective imagination. The popular press is filled with against-all-odds success stories of Silicon Valley entrepreneurs. In these sagas, the entrepreneur is the modern-day cowboy, roaming new industrial frontiers much the same way that earlier Americans explored the West. At his side stands the venture capitalist, a trail-wise sidekick ready to help the hero through all the tight spots—in exchange, of course, for a piece of the action.
The venture capital funnel highlights the natural selection process of the venture capital process. Three-fourths of companies are orphaned or die along the way.
Once you take venture capital, what can you expect? Below is what the data says life will look like.
With 2014 breaking all records for digital health funding, we entered 2015 wondering if the pace would continue. We shouldn’t have been doubtful—digital health funding in 2015 matched the total of 2014, surpassing $4.3B in funding. While skeptics may use the flatness of growth to question the attractiveness of the digital health industry, it’s important to keep in perspective what an incredible feat it was for 2015 to be on track with record-breaking 2014.
In the past couple of years there has been a rise in sovereign wealth funds’ investments in healthcare. These cover a wide range of areas from hospital chains to pharmaceutical companies, but it also includes direct investments in digital health startups. China Broadband Capital invested in smartphone diagnostic developer Scanadu and French Groupe Arnault includes Clue, a maker of female health apps, among its investments.
El volumen de transacciones con venture capital, o capital riesgo para empresas de nueva creación, batirá este año su plusmarca, con un incremento del 42% sobre 2014.
España empieza a desmontar el maldito eslogan "que inventen otros". Este año, el venture capital, o capital riesgo para apoyo de nuevas empresas, batirá un récord de operaciones. Así lo asegura Javier Ulecia, socio fundador de Bullnet Capital, uno de los fondos especializados en este segmento.
Hace cinco años, Jason Calacanis, un inversionista especializado en startups, hizo una apuesta de US$25.000 por una empresa de la cual casi nadie había oído hablar: UberCab. La inversión en lo que hoy es UberTechnologies Inc. vale ahora cerca de US$110 millones.
Calacanis nunca ha revelado públicamente de dónde provino el dinero: Sequoia Capital. A partir de 2009, una de las mayores firmas de capital de riesgo de Silicon Valley ha distribuido millones de dólares a múltiples grupos de empresarios y académicos bien conectados y otras personas conocidas como scouts, o cazatalentos.
